Meeting
2019 ASCO Annual Meeting
Physician concordance with update to ASCO guidelines for antiemetic use with carboplatin AUC ≥ 4.
Authors
Rudolph M. Navari
University of Alabama at Birmingham, Birmingham, AL
Rudolph M. Navari , Kathryn Jean Ruddy , Thomas William LeBlanc , Rebecca Anne Clark-Snow , Rita S. Wickham , Gary Binder , Tammy Bratton Coberly , Ravi C. Potluri , Luke M. Schmerold , Eric Roeland
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Palliative Care and Symptom Management
Citation
J Clin Oncol 37, 2019 (suppl; abstr 11595)
DOI
10.1200/JCO.2019.37.15_suppl.11595
Abstract #
11595
Poster Bd #
287
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting (CINV): Results of the Nausea/Emesis Registry in Oncology (NERO).
First Author: Matti S. Aapro
Poster
2020 ASCO Virtual Scientific Program
Antiemetic prophylaxis with NEPA: Final results of the German AKYPRO study.
First Author: Joerg Peter Schilling
Poster
2017 ASCO Annual Meeting
Chemotherapy induced nausea and vomiting in breast cancer treated with antiemetic prophylaxis as recommended by the ASCO antiemesis guidelines.
First Author: Ronda Copher
Poster
2016 ASCO Annual Meeting
Placebo-controlled phase III study comparing dexamethasone on day 1 to on day 1-3 with NK1 receptor antagonist and palonosetoron in high emetogenic chemotherapy.
First Author: Kunihiro Matsuzaki